Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FH and High LDL-C in Risk of Ischemic Stroke

Circulation; ePub 2018 Mar 28; Beheshti, et al

Familial hypercholesterolemia (FH) and high concentrations of low-density lipoprotein cholesterol (LDL-C) did not confer an increased risk of ischemic stroke, a recent study found. The associations of FH and high LDL-C with ischemic stroke risk were tested in causal, genetic, and observational analyses using 106,412 individuals from the Copenhagen General Population Study (CGPS) and/or 10,372 individuals from the Copenhagen City heart study (CCHS). Researchers found:

  • The cumulative incidences in individuals in the CGPS with and without FH causative mutations were similar for ischemic stroke, but not for myocardial infarction (MI); results were similar in the CCHS.
  • There was no association between clinical FH and ischemic stroke, expect if personal premature ischemic heart disease was included in the clinical FH criteria.
  • Ischemic heart disease at baseline was associated with higher ischemic stroke risk.
  • For a 1 mmol/L higher LDL-C, the genetic causal risk ratio was 1.11 for ischemic stroke and 1.45 for MI.

Citation:

Beheshti S, Madsen CM, Varbo A, Benn M, Nordestgaard BG. Relationship of familial hypercholesterolemia and high LDL cholesterol to ischemic stroke: The Copenhagen General Population Study. [Published online ahead of print March 28, 2018]. Circulation. doi:10.1161/CIRCULATIONAHA.118.033470.

This Week's Must Reads

Anticoagulation in Patients with AF and HF, Clin Cardiol; ePub 2018 Dec 23; Contreras, et al

Serum Uric Acid, Silent MI & Mortality, Am J Cardiol; ePub 2018 Dec 19; Ahmad, et al

Catheter Ablation for AF in Adults with CHD, Heart Rhythm; ePub 2018 Dec 26; Liang, et al

Cognitive Impairment in Adults with Incident HF, J Card Fail; ePub 2018 Dec 22; Sterling, et al

LDL-C Level Reduction Consistent with Evolocumab , JAMA Cardiol; ePub 2018 Dec 12; Qamar, et al

Must Reads in Hypercholesterolemia

LDL-C Level Reduction Consistent with Evolocumab , JAMA Cardiol; ePub 2018 Dec 12; Qamar, et al

Hypertriglyceridemia in Statin-Treated Adults, J Clin Lipidol; ePub 2018 Dec 1; Fan, et al

AHA Statement: Statin Safety & Adverse Events, Arterioscler Thromb Vasc Biol; ePub 2018 Dec 10; Newman, et al

LDL-C Reduction & Arterial Wall Inflammation, Eur Heart J; ePub 2018 Dec 18; Stiekema, et al

Holiday Season and Risk of Hypercholesterolemia, Atherosclerosis; ePub 2018 Dec 19; Vedel-Krogh, et al